These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38803504)

  • 21. Cereal Fiber Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by Modulating the NLRP3 Inflammasome Pathway in ApoE
    Zhang R; Han S; Zhang Z; Zhang W; Yang J; Wan Z; Qin L
    J Agric Food Chem; 2018 May; 66(19):4827-4834. PubMed ID: 29664631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice.
    Zhao J; Wang Z; Yuan Z; Lv S; Su Q
    Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophages regulate plaque progression in diabetic Apoe
    Liu WX; Hu YF; Tai GJ; Li YP; Li JP; Qiu S; Zheng RF; Damdinjav D; Otieno JN; Li XX; Xu M
    Atherosclerosis; 2024 Oct; 397():118556. PubMed ID: 39222595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
    Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
    Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.
    Zeng W; Wu D; Sun Y; Suo Y; Yu Q; Zeng M; Gao Q; Yu B; Jiang X; Wang Y
    Sci Rep; 2021 Sep; 11(1):19305. PubMed ID: 34588488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.
    Zhang X; Wang Z; Li X; Chen J; Yu Z; Li X; Sun C; Hu L; Wu M; Liu L
    J Ethnopharmacol; 2023 Jun; 309():116304. PubMed ID: 36870461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
    Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
    Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia activates macrophage-NLRP3 inflammasome promoting atherosclerosis via PFKFB3-driven glycolysis.
    Wang X; Liu X; Wu W; Liao L; Zhou M; Wang X; Tan Z; Zhang G; Bai Y; Li X; Zhao M
    FASEB J; 2024 Aug; 38(15):e23854. PubMed ID: 39096131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corilagin Counteracts IL-13Rα1 Signaling Pathway in Macrophages to Mitigate Schistosome Egg-Induced Hepatic Fibrosis.
    Li YQ; Chen YF; Dang YP; Wang Y; Shang ZZ; Ma Q; Wang YJ; Zhang J; Luo L; Li QQ; Zhao L
    Front Cell Infect Microbiol; 2017; 7():443. PubMed ID: 29094025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway.
    Chen ML; Zhu XH; Ran L; Lang HD; Yi L; Mi MT
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
    Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
    Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
    Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
    Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE
    Tang G; Duan F; Li W; Wang Y; Zeng C; Hu J; Li H; Zhang X; Chen Y; Tan H
    Biomed Pharmacother; 2019 Nov; 119():109410. PubMed ID: 31518877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corilagin alleviates LPS-induced sepsis through inhibiting pyroptosis via targeting TIR domain of MyD88 and binding CARD of ASC in macrophages.
    Wu S; Liao J; Hu G; Yan L; Su X; Ye J; Zhang C; Tian T; Wang H; Wang Y
    Biochem Pharmacol; 2023 Nov; 217():115806. PubMed ID: 37714273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis.
    Guo S; Wang L; Cao K; Li Z; Song M; Huang S; Li Z; Wang C; Chen P; Wang Y; Dai X; Chen X; Fu X; Feng D; He J; Huo Y; Xu Y
    Cardiovasc Res; 2024 Jul; 120(8):883-898. PubMed ID: 38626254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy.
    Lin X; Wang H; An X; Zhang J; Kuang J; Hou J; Yan M
    Phytomedicine; 2021 Apr; 84():153521. PubMed ID: 33667838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway.
    Zhang H; Gong X; Ni S; Wang Y; Zhu L; Ji N
    Int Immunopharmacol; 2019 Dec; 77():105934. PubMed ID: 31727560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE
    Leng W; Ouyang X; Lei X; Wu M; Chen L; Wu Q; Deng W; Liang Z
    Mediators Inflamm; 2016; 2016():6305735. PubMed ID: 28104929
    [No Abstract]   [Full Text] [Related]  

  • 40. Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway.
    Jiang Y; Du H; Liu X; Fu X; Li X; Cao Q
    J Drug Target; 2020 Jan; 28(1):70-79. PubMed ID: 31094238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.